Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation

被引:9
|
作者
Ndiaye, Ousseynou [1 ]
Diop-Ndiaye, Halimatou [1 ]
Ouedraogo, Abdou Salam [2 ]
Fall-Malick, Fatim Zahra [1 ]
Sow-Sall, Amina [1 ]
Thiam, Moussa [1 ]
Diouara, Abou Abadallah Malick [1 ]
Ndour, Cheikh Tidiane [1 ]
Gaye-Diallo, Aissatou [1 ]
Mboup, Souleymane [1 ]
Toure-Kane, Coumba [1 ]
机构
[1] Univ Cheikh Anta Diop Dakar, Lab Bacteriol Virol, CHU A Dantec, Dakar, Senegal
[2] Univ Ouagadougou, CHU Souro Sanou, Serv Bacteriol Virol, Bobo Dioulasso, Burkina Faso
关键词
HIV-1; Viral load; Comparison; GENETIC DIVERSITY; RNA QUANTITATION; MONITOR V1.5; TAQMAN HIV-1; ASSAYS; PERFORMANCE; AMPLICOR; FAILURE; RESISTANCE; INFECTION;
D O I
10.1016/j.jviromet.2015.06.002
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to compare four HIV-1 viral quantitation platforms, Nuclisens EasyQ v2.0 (R) (EQ), COBAS AmpliPreP/Cobas Tagman (R) HIV-1 test v 2.0 (CTM), GENERIC HIV CHARGE VIRALE (R) (GEN), with Abbott Real Time HIV-1 (R) (m2000sp/rt) as reference technique. The study had first evaluated m2000sp/rt performances and then compared quantitation between techniques. Discordant samples were genotyped on gag and pal gene and sequences were analyzed using Sequence locator and SeqPublish to detect eventual mismatches. Performance analysis of m2000sp/rt showed good results with coefficients of variation values (CV) of 1.35%, 0.65%, and 0.54% for repeatability testing of low, intermediate and high concentrations, respectively. Reproducibility tests showed low CV values with 2.36% and 1.42% for low and high concentration levels, respectively and contamination test was very low value with 0.94%. Correlation and concordance between techniques ranged from r(2) = 0.98 and bias = -0.00185 (for m2000sp/rt vs CTM) to r(2) = -0.90 and bias = -0.135 (for EQ vs GEN). Discrepancies were observed on 37 samples mostly CRF02_AG but despite some mismatches, sequence analysis (26/37) did not show any remarkable differences between CRF02_AG queries and references. This study showed good correlation and good concordance between techniques. However, EQ yielded under-quantitation of CRF02_AG. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 50 条
  • [1] HIV-1 Non-B subtypes in Italy: a growing trend
    Ciccozzi, Massimo
    Santoro, Maria Mercedes
    Giovanetti, Marta
    Andrissi, Laura
    Bertoli, Ada
    Ciotti, Marco
    NEW MICROBIOLOGICA, 2012, 35 (04): : 377 - 386
  • [2] Comparison of Three Different Commercial Methods for Measuring Plasma Viraemia in Patients Infected with Non-B HIV-1 Subtypes
    A. Holguín
    C. de Mendoza
    V. Soriano
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 256 - 259
  • [3] Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes
    Holguín, A
    de Mendoza, C
    Soriano, V
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (04) : 256 - 259
  • [4] Atazanavir susceptibility spectrum extends to HIV-1 non-B subtypes and HIV-2 viral isolates
    Gong, Y-F
    Eggers, B.
    Yang, H.
    Gali, V.
    Lin, P-F
    Parkin, N.
    McCallister, S.
    Colonno, R. J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S100 - S100
  • [5] Comparison of the Generic HIV Viral Load® assay with the Amplicor™ HIV-1 Monitor v1.5 and Nuclisens HIV-1 EasyQ® v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: The Kesho Bora preparatory study
    Rouet, Francois
    Foulongne, Vincent
    Viljoen, Johannes
    Steegen, Kim
    Becquart, Pierre
    Valea, Diane
    Danaviah, Sivapragashini
    Segondy, Michel
    Verhofstede, Chris
    Van de Perre, Philippe
    JOURNAL OF VIROLOGICAL METHODS, 2010, 163 (02) : 253 - 257
  • [6] Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide
    Holguin, Africa
    Faudon, Jean Louis
    Labernadeire, Jean-Louis
    Soriano, Vincent
    JOURNAL OF CLINICAL VIROLOGY, 2007, 38 (02) : 176 - 180
  • [7] Longstanding presence in Belgians of multiple non-B HIV-1 subtypes
    Fransen, K
    Buve, A
    Nkengasong, JN
    Laga, M
    vanderGroen, G
    LANCET, 1996, 347 (9012): : 1403 - 1403
  • [8] The prevalence of HIV-1 non-B subtypes in a London HIV/AIDS outpatient department
    Burke, A
    Devereux, H
    Norville, N
    Johnson, M
    Loveday, C
    AIDS, 1998, 12 : S70 - S70
  • [9] Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine
    Braun, Patrick
    Ehret, Robert
    Wiesmann, Frank
    Zabbal, Frauke
    Knickmann, Mechthild
    Kuehn, Rainer
    Thamm, Sven
    Warnat, Gerald
    Knechten, Heribert
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (01) : 93 - 99
  • [10] Comparison of five interpretation algorithms for the prediction of protease inhibitor susceptibility in HIV-1 non-B subtypes
    Snoeck, J
    Kantor, R
    Shafer, RW
    Derdelinckx, I
    Carvalho, AP
    Wynhoven, B
    Soares, MA
    Cane, P
    Clarke, J
    Pillay, C
    Sirivichayakul, S
    Ariyoshi, K
    Holguin, A
    Rudich, H
    Rodrigues, R
    Bouzas, MB
    Van Laethem, K
    Brun-Vézinet, F
    Reid, C
    Cahn, P
    Brigido, LF
    Grossman, Z
    Soriano, V
    Sugiura, W
    Phanuphak, P
    Morris, L
    Weber, J
    Pillay, D
    Tanuri, A
    Harrigan, PR
    Camacho, R
    Schapiro, JM
    Katzenstein, D
    Vandamme, AM
    ANTIVIRAL THERAPY, 2003, 8 (03) : U98 - U99